Genincode (GENI.L) Stock Price
Genincode Price
Revenue has compounded at 29.5% per year over the past 4 years to 2.70 M GBP. Genincode's net margin stands at -164.2%, down from -121.9% several years earlier. The stock trades about 11,504% above its 52-week low.
Genincode stock price
Genincode business model & stock analysis
Frequently asked questions about Genincode
5 analysts currently rate the Genincode stock: 4 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Genincode share trades at 1.05 EUR (0.90 GBP).
The Genincode share (GENI.L) is listed on 3 stock exchanges, including: London (GENI.L), Frankfurt (9PL.F).
No history available for Genincode.
The expected revenue of Genincode is 4.75 M GBP. This figure is based on current financial data and reflects the company's business performance.
The profit cannot currently be calculated for Genincode.
The P/E ratio cannot be calculated for Genincode at the moment.
The price-to-sales ratio (P/S) of Genincode is currently 33.16. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Genincode stock.
The Eulerpool Quality Score for Genincode is 3/10.
The ISIN of Genincode is GB00BL97B504. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Genincode is A3C31Y. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Genincode is GENI.L. The ticker symbol is used to trade Genincode shares on the stock exchange.
Genincode paid dividends every year for the past 0 years.
Genincode is assigned to the 'Health' sector.
The dividends of Genincode are distributed in GBP.
Genincode stock
Genincode Peer Group
Genincode Ticker
Genincode FIGI
All fundamentals and in-depth analysis of Genincode
Our stock analysis for Genincode stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genincode. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.